HuGE Literature Finder
Records 1-11
|
Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2017 Apr . Park Yun Kyung, Lee Mi Ji, Kim Jae Ha, Lee Jin Soo, Park Rae Woong, Kim Gyeong-Moon, Chung Chin-Sang, Lee Kwang Ho, Kim June Soo, Lee Soo-Youn, Bang Oh You |
|
Comparison of aspirin and Naoxintong Capsule () with adjusted-dose warfarin in elderly patients with high-risk of non-valvular atrial fibrillation and genetic variants of vitamin K epoxide reductase.
Chinese journal of integrative medicine 2016 Feb . Wang Huan, Zhou Xiao-Kai, Zheng Li-Fan, Wu Xiao-Ying, Chen H |
|
[HORMONAL-GENETIC SCREENING IN PATIENTS, SUFFERING GASTRODUODENAL ULCER HEMORRHAGE].
Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukrai?ny, Naukove tovarystvo khirurhiv Ukrai?ny 2015 Nov (11): 24-7. Duzhiy I D, Romanyuk A M, Lyndin M C, Bratushka V V, Dubnytskiy V Yu, Shevchenko Yu Yu, Kharchenko S |
|
Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis.
International journal of cardiology 2013 Oct 168 (4): 4234-43. Yang Jie, Chen Yanming, Li Xiaoqi, Wei Xiaowen, Chen Xi, Zhang Lanning, Zhang Yuxiao, Xu Qiang, Wang Hongjuan, Li Yang, Lu Caiyi, Chen Wei, Zeng Changqing, Yin To |
|
Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.
International journal of hematology 2012 Dec 96 (6): 719-28. Ma Cong, Zhang Yuxiao, Xu Qiang, Yang Jie, Zhang Yan, Gao Lei, Xu Bin, Wang Hongjuan, Li Yang, Lu Caiyi, Yin To |
|
[CYP2C9 and VKORC1 gene polymorphism and acenocoumarol anticoagulant activity in Russian patients at high risk of thromboembolic complications].
Vestnik Rossi?sko? akademii meditsinskikh nauk / Rossi?skaia akademiia meditsinskikh nauk 2011 (3): 3. Authors are not available |
|
[Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage].
Terapevticheski? arkhiv 2011 83 (6): 59-65. Vorob'eva N M, Panchenko E P, Dobrovol'ski? A B, Titaeva E V, Khasanova Z B, Konovalova N V, Postnov A Iu, Kirienko A |
|
Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.
International heart journal 2011 52 (1): 44-9. Miyagata You, Nakai Kenji, Sugiyama Yoshi |
|
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
Clinical pharmacology and therapeutics 2008 Sep 84 (3): 326-31. Gage B F, Eby C, Johnson J A, Deych E, Rieder M J, Ridker P M, Milligan P E, Grice G, Lenzini P, Rettie A E, Aquilante C L, Grosso L, Marsh S, Langaee T, Farnett L E, Voora D, Veenstra D L, Glynn R J, Barrett A, McLeod H |
|
Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarin.
Clinical pharmacology and therapeutics 2008 Feb 83 (2): 312-21. Limdi N A, McGwin G, Goldstein J A, Beasley T M, Arnett D K, Adler B K, Baird M F, Acton R |
|
Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy.
Blood cells, molecules & diseases 0 43 (1): 119-28. Limdi N A, Wiener H, Goldstein J A, Acton R T, Beasley T |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 27, 2021
- Content source: